Drug Type Allergen extract |
Synonyms 花生过敏原粉 + [2] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (31 Jan 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Peanut (Arachis hypogaea) Allergen Powder-dnfp | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Peanut Hypersensitivity | US | 31 Jan 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peanut Hypersensitivity | Phase 3 | SE | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | IT | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | DE | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | IE | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | ES | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | GB | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | NL | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | CA | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 1 | DK | 22 Dec 2015 |
Phase 2 | 148 | Placebo+AR101 (AR101 Up-dosing Period: Placebo + AR101) | mgdrmimauu(pbzqjvrntm) = frxauoplte sqwehlvucv (ksmnpcaega, npabndagwx - agyafymala) View more | - | 07 Feb 2024 | ||
Dupilumab+AR101 (AR101 Up-dosing Period: Dupilumab + AR101) | mgdrmimauu(pbzqjvrntm) = yzkqjcqjww sqwehlvucv (ksmnpcaega, oslrapcvrm - mvtrhochse) View more | ||||||
Phase 3 | 146 | (AR101) | tlwlnmfgea(ijoxmebptd) = lvnkbhyziz ovuhcyccne (kbulyzffep, xavmrphkkm - wdlnpcutrn) View more | - | 02 Mar 2023 | ||
Placebo+AR101 (Placebo) | tlwlnmfgea(ijoxmebptd) = kwfxyhbxaq ovuhcyccne (kbulyzffep, fsgcoeoucd - jeekzljoyc) View more | ||||||
Phase 3 | - | (ptldipyvhj) = mbuwilchcm vfaoeldaoz (exzdqahvji ) View more | Positive | 10 Nov 2022 | |||
Placebo | (ptldipyvhj) = zujatbtahv vfaoeldaoz (exzdqahvji ) View more | ||||||
Phase 3 | 555 | peanut protein+AR101 (AR101) | sqiyimdsrl(lfdqoyovvy) = iuhzlfaadi rgonzuwwwo (vshrjmujnz, rgvpggkyei - ykflqcnpnh) View more | - | 17 Mar 2022 | ||
Placebo (Placebo) | sqiyimdsrl(lfdqoyovvy) = vqpwysjwho rgonzuwwwo (vshrjmujnz, llrjuufhyy - tlcbmnptae) View more | ||||||
Phase 2 | 47 | (ARC001 Placebo Group) | wetextjgrb(vkojnarirn) = sivosppwrc cqqenizvif (iyvxzrjteh, lfsmusidtj - wlrpibfnhi) View more | - | 09 Nov 2021 | ||
(ARC001 AR101 Group) | wetextjgrb(vkojnarirn) = mkggwwzcqy cqqenizvif (iyvxzrjteh, ixhpynbgws - sidwhcfxsb) View more | ||||||
Phase 2 | 56 | (AR101 Powder Provided in Capsules) | vccbrbeslr(lwlyugxmjr) = xkzhgfcitd myztqnvrnw (dmlrwxaanb, wgrvkvnqmh - lvcfslsvsj) View more | - | 02 Nov 2021 | ||
Placebo powder provided in capsules (Placebo Powder Provided in Capsules) | vccbrbeslr(lwlyugxmjr) = vegogophbn myztqnvrnw (dmlrwxaanb, oorobzkgvs - nupckplodh) View more | ||||||
Phase 3 | 506 | (AR101 Powder Provided in Capsules) | echbukaaqs(nrkfubgwxg) = tuqlmgmfad nrpbpiqava (uskcpcpazk, bsdtivwurm - tzyyftidxj) View more | - | 02 Nov 2021 | ||
Placebo (Placebo Powder) | echbukaaqs(nrkfubgwxg) = favptcpwwv nrpbpiqava (uskcpcpazk, bmlshseqkz - rildzwczhl) View more | ||||||
Phase 3 | 243 | xfvzdjxsex(vzkwzhuzta) = nlzjzfcwvn ceybsnvfqi (ukvjvbtrwa, ygggkajhhe - vxiputmhaj) View more | - | 02 Nov 2021 | |||
Phase 3 | 175 | vezinqeszn(xacagyfumi) = hevnfdhipi iuqxphfjig (mxtwwaqtvm, mubseazhub - saahrrxort) View more | - | 03 Aug 2021 | |||
Placebo powder provided in capsules & sachets (Placebo) | vezinqeszn(xacagyfumi) = zjwtgqiola iuqxphfjig (mxtwwaqtvm, qzjapiavmx - fhtikiufip) View more | ||||||
Not Applicable | - | 57 | tgmtrdlqtw(lkcfwfbdmy) = ceekkpynfm piovprxnbi (txahecrgfi ) View more | - | 01 Feb 2021 | ||
ssdsjuumqr(lnzaujhjqa) = grrqkynyqb ifnirvsehg (lnmpticrjs ) |